A detailed history of Swiss National Bank transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Swiss National Bank holds 973,092 shares of ELAN stock, worth $13.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
973,092
Previous 973,092 -0.0%
Holding current value
$13.4 Million
Previous $15.8 Million 11.36%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$14.37 - $16.46 $31,614 - $36,212
2,200 Added 0.23%
973,092 $15.8 Million
Q4 2023

Feb 06, 2024

SELL
$8.6 - $14.94 $960,620 - $1.67 Million
-111,700 Reduced 10.32%
970,892 $14.5 Million
Q3 2023

Nov 08, 2023

BUY
$9.81 - $12.62 $33,354 - $42,908
3,400 Added 0.32%
1,082,592 $12.2 Million
Q2 2023

Aug 09, 2023

SELL
$8.08 - $10.37 $4.93 Million - $6.33 Million
-610,000 Reduced 36.11%
1,079,192 $10.9 Million
Q1 2023

May 10, 2023

SELL
$8.79 - $14.58 $314,681 - $521,964
-35,800 Reduced 2.08%
1,689,192 $15.9 Million
Q4 2022

Feb 08, 2023

SELL
$11.49 - $13.65 $1.33 Million - $1.58 Million
-115,825 Reduced 6.29%
1,724,992 $21.1 Million
Q3 2022

Nov 09, 2022

SELL
$12.41 - $32.42 $43,435 - $113,470
-3,500 Reduced 0.19%
1,840,817 $22.8 Million
Q2 2022

Aug 09, 2022

BUY
$19.63 - $26.62 $1,963 - $2,662
100 Added 0.01%
1,844,317 $36.2 Million
Q1 2022

May 09, 2022

BUY
$24.65 - $29.0 $5.58 Million - $6.56 Million
226,200 Added 13.98%
1,844,217 $48.1 Million
Q4 2021

Feb 08, 2022

SELL
$27.74 - $34.09 $1.87 Million - $2.3 Million
-67,400 Reduced 4.0%
1,618,017 $45.9 Million
Q3 2021

Nov 08, 2021

SELL
$29.2 - $36.72 $1.38 Million - $1.74 Million
-47,400 Reduced 2.74%
1,685,417 $53.7 Million
Q2 2021

Aug 06, 2021

BUY
$28.76 - $35.98 $2.89 Million - $3.61 Million
100,396 Added 6.15%
1,732,817 $60.1 Million
Q1 2021

May 07, 2021

BUY
$27.85 - $34.49 $1.43 Million - $1.78 Million
51,500 Added 3.26%
1,632,421 $48.1 Million
Q4 2020

Feb 05, 2021

BUY
$27.53 - $33.79 $784,605 - $963,015
28,500 Added 1.84%
1,580,921 $48.5 Million
Q3 2020

Nov 09, 2020

SELL
$21.1 - $29.13 $497,960 - $687,468
-23,600 Reduced 1.5%
1,552,421 $43.4 Million
Q2 2020

Aug 05, 2020

BUY
$18.94 - $24.93 $763,282 - $1 Million
40,300 Added 2.62%
1,576,021 $33.8 Million
Q1 2020

May 08, 2020

BUY
$16.68 - $32.25 $6.98 Million - $13.5 Million
418,400 Added 37.45%
1,535,721 $34.4 Million
Q4 2019

Feb 06, 2020

SELL
$25.29 - $29.45 $1.31 Million - $1.52 Million
-51,700 Reduced 4.42%
1,117,321 $32.9 Million
Q3 2019

Nov 12, 2019

BUY
$25.62 - $34.96 $7.08 Million - $9.67 Million
276,515 Added 30.98%
1,169,021 $31.1 Million
Q2 2019

Aug 02, 2019

SELL
$31.11 - $34.79 $979,965 - $1.1 Million
-31,500 Reduced 3.41%
892,506 $30.2 Million
Q1 2019

May 10, 2019

BUY
$29.0 - $32.83 $26.8 Million - $30.3 Million
924,006 New
924,006 $29.6 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.51B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.